Drigalenko E, Poduslo S, Elston R
Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, OH 44109-1998, USA.
Neurology. 1998 Jul;51(1):131-5. doi: 10.1212/wnl.51.1.131.
The association between Alzheimer's disease (AD) and alleles at the ApoE and the ApoCI loci were tested.
The ApoE alleles, in linkage disequlibrium with ApoCI alleles, have been reported as associated with (epsilon4) or protective for (epsilon2) AD.
The patients comprise two samples, with a total of 176 whose diagnosis has been confirmed as having probable AD and 226 controls. Genomic DNA was extracted from blood or transformed lymphocytes. Logistic regression was used to determine the effects of alleles at the ApoE and ApoCI loci after allowing for the effects of age and gender.
The effects of the ApoE epsilon2, epsilon3, and epsilon4 alleles were individually studied first; ignoring the ApoCI locus, only the dominant or additive effect of epsilon4 is significant after considering age, gender, and sample--the dominant effect being slightly more significant. The effect of epsilon4 (when only the ApoE locus is included in the model) was larger than recently reported: the odds ratio was 5.57 (95% CI, 3.46 to 8.98). Similarly, when the ApoCI locus was examined, ignoring the ApoE locus, a dominant effect of A was found to be slightly more significant than an additive effect. Finally, models were considered that included the dominant effect of epsilon4, the dominant effect of A, and their interaction. A model that included only the interaction of ApoE and ApoCI yielded the largest odds ratio, 5.89 (95% CI, 3.64 to 9.53).
Association of AD with both the ApoE epsilon4 and ApoCI A alleles was found. The increased risk of AD among carriers of epsilon4 was found to be higher among those who also bear the ApoCI A allele but this may be due to a dose effect of the epsilon4 allele.
检测阿尔茨海默病(AD)与载脂蛋白E(ApoE)及载脂蛋白CⅠ(ApoCI)基因座等位基因之间的关联。
已报道ApoE等位基因与ApoCI等位基因处于连锁不平衡状态,与AD相关(ε4)或具有保护作用(ε2)。
患者包括两个样本,共176例确诊为可能患有AD的患者和226例对照。从血液或转化的淋巴细胞中提取基因组DNA。在考虑年龄和性别的影响后,使用逻辑回归来确定ApoE和ApoCI基因座等位基因的作用。
首先分别研究了ApoE ε2、ε3和ε4等位基因的作用;忽略ApoCI基因座,在考虑年龄、性别和样本后,只有ε4的显性或加性效应显著——显性效应略更显著。ε4的效应(当模型中仅包括ApoE基因座时)比最近报道的更大:优势比为5.57(95%可信区间,3.46至8.98)。同样,当检查ApoCI基因座时,忽略ApoE基因座,发现A的显性效应比加性效应略更显著。最后,考虑了包括ε4的显性效应、A的显性效应及其相互作用的模型。仅包括ApoE和ApoCI相互作用的模型产生了最大的优势比,为5.89(95%可信区间,3.64至9.53)。
发现AD与ApoE ε4和ApoCI A等位基因均有关联。在同时携带ApoCI A等位基因的个体中,ε4携带者患AD的风险增加更高,但这可能是由于ε4等位基因的剂量效应。